Form 4 for CGON CG Oncology, Inc.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-16 · accession 0001193125-26-110831 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-03-17 | 2026-03-16 | CGON | Mulay James | Dir | M - OptEx | $9.64 | +1,964 | 654 | New | +$18.9K |
| DMT | 2026-03-17 | 2026-03-16 | CGON | Mulay James | Dir | S - Sale+OE | $63.50 | -1,964 | 0 | -100% | -$124.7K |
| DMT | 2026-03-17 | 2026-03-16 | CGON | Mulay James | Dir | M - OptEx | $0.00 | -1,964 | 3,930 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-16 | M | A | 1,310 | $12.59 | 1,310 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-16 | M | A | 654 | $3.72 | 654 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-16 | S | D | 654 | $63.50 | 0 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-16 | S | D | 1,310 | $63.50 | 0 | D | — | — | |
| 5 | Derivative | Director Stock Option (right to buy) | 2026-03-16 | M | D | 654 | $0.00 | 654 | D | $3.72 · — to 2033-06-13 | 654 Common Stock | (F2) The stock option vests in 36 substantially equal monthly installments beginning on July 14, 2023. |
| 6 | Derivative | Director Stock Option (right to buy) | 2026-03-16 | M | D | 1,310 | $0.00 | 3,930 | D | $12.59 · — to 2033-12-12 | 1,310 Common Stock | (F3) The stock option vests in 36 substantially equal monthly installments beginning on January 13, 2024. |